Modulation of pathogenicity

Details Modulation of pathogenicity Modulation of pathogenicity

2008-03-04

2008-03-04

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S372000, C514S374000

Reexamination Certificate

active

10839221

ABSTRACT:
The present invention relates to the use of compounds of the general Formula (XIII):whereinA7is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13;A8is C(R14)2, O, S, or NR12;A9is C═O, C═S, SO2, CH—OR13, C═NR12,or CH2—CHOR13;m is 0, or 1q is 0, or 1r is 0, or 1R12is H, CH3, CH2—CH3, C6H5, OCH3, OCH2—CH3, OH, or SH;R13is H, CH3, or CH2—CH3;R14is H, alkyl, alkoxy, OH, or SH.

REFERENCES:
patent: 3265506 (1966-08-01), Weissberger et al.
patent: 4069252 (1978-01-01), Findeisen
patent: 4146454 (1979-03-01), Haber
patent: 4436479 (1984-03-01), Belloli
patent: 5155011 (1992-10-01), Zertani
patent: 5190928 (1993-03-01), Schurter
patent: 5395730 (1995-03-01), Podszun
patent: 5523311 (1996-06-01), Schurter
patent: 5585473 (1996-12-01), Bendiak
patent: 5612359 (1997-03-01), Murugesan
patent: 5846990 (1998-12-01), Murugesan
patent: 5990109 (1999-11-01), Chen
patent: 6159980 (2000-12-01), Arvanitis
patent: 6300352 (2001-10-01), Cheshire
patent: 6395282 (2002-05-01), Kende et al.
patent: 6399773 (2002-06-01), Liu
patent: 6476042 (2002-11-01), Harrison
patent: 6555540 (2003-04-01), Mylari
patent: 6815528 (2004-11-01), Wang
patent: 6858627 (2005-02-01), Bekkali
patent: 6894111 (2005-05-01), Wang
patent: 2004/0019117 (2004-01-01), Protopopova
patent: 2004/0033986 (2004-02-01), Protopopova
patent: 2006/0073667 (2006-04-01), Li
patent: 101 18 310 (2002-10-01), None
patent: 0 525 686 (1993-02-01), None
patent: 0 540 472 (1993-05-01), None
patent: 0 638 545 (1995-02-01), None
patent: 0 982 292 (2000-03-01), None
patent: 1 439 334 (1966-04-01), None
patent: 2 331 299 (1999-05-01), None
patent: 3-232849 (1991-10-01), None
patent: 95/01175 (1995-01-01), None
patent: WO 95/24403 (1995-09-01), None
patent: 96/29392 (1996-09-01), None
patent: 98/57618 (1998-12-01), None
patent: 98/58075 (1998-12-01), None
patent: WO 98/57618 (1998-12-01), None
patent: WO 99/27786 (1999-06-01), None
patent: 99/53915 (1999-10-01), None
patent: 99/55368 (1999-11-01), None
patent: 01/26650 (2001-04-01), None
patent: 01/51456 (2001-07-01), None
patent: WO 01/90090 (2001-11-01), None
patent: 02/088298 (2002-11-01), None
patent: 03/004017 (2003-01-01), None
patent: WO/03/015778 (2003-02-01), None
patent: 03/022828 (2003-03-01), None
patent: 03/026641 (2003-04-01), None
patent: WO 03/039529 (2003-05-01), None
patent: WO 03/039549 (2003-05-01), None
Hentzer, M., et al. Microbiology 2002, 148, 87-102.
Patent Abstracts of Japan, JP 59-210440, Nov. 29, 1984.
C. S. Pak, et al., Synthesis, vol. 12, XP-001154580, pp. 1213-1214, “Aminolysis of 5-Acyl-2,2-Dimethyl-1,3-Dioxane-4,6-Diones (Acyl Meldrum's Acids) as a Versatile Method for the Synthesis of β-Oxo Carboxamides”, Dec. 1992.
K. M. Smith, et al., Chemistry & Biology, vol. 10, No. 1, XP-002254860, pp. 81-89, “Induction and Inhibition ofPseudomonas aeruginosaQuorum Sensing by Synthetic Autoinducer Analogs”, Jan. 2003.
Fuqua, C., et al., “Census and Consensus in Bacterial Ecosystems: The LuxR-LuxI Family of Quorum-Sensing Transcriptional Regulators,” Anne. Rev. Microbiol. 50, pp. 727-751, 1996.
Eberl, L., “N-Acyl Homoserinelactone-mediated Gene Regulation in Gram-negative Bacteria,” System Appl. Microbiol. 22, pp. 493-506, 1999.
De Kievit, T., et al., “Bacterial Quorum Sensing in Pathogenic Relationships,” Infection and Immunity, pp. 4839-4849, Sep. 2000.
Davies, D. G., et al., “The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm,” Science, vol. 280, pp. 295-298, Apr. 10, 1998.
Huber, B., et al., “The cep quorum-sensing system ofBurkholderia cepaciaH111 controls biofilm formation and swarming motility,” Microbiology, 147, pp. 2517-2528, 2001.
Costerton, J. W., et al., “Microbial Biofilms,” Ann. Rev. Microbiol.
Govan, J. R. W., et al., “Microbial Pathogenesis in Cystic Fibrosis: MucoidPseudomonas aeruginosaandBurkholderia cepacia,” Microbiological Reviews, Sep. 1996, pp. 539-574.
Costerton, J. W., et al., “Bacterial Biofilms: A Common Cause of Persistent Infections,” Science, vol. 284, May 21, 1999, pp. 1318-1322.
Lewis, K., “Riddle of Biofilm Resistance,” Antimicrobial Agents and Chemotherapy, Apr. 2000, pp. 999-1007.
Govan, J. R. W., “Burkholderia cepacia:medical, taxonomic and ecological issues,” J. Med. Microbiol. 45, pp. 395-407, 1996.
Chhabra, S. R., et al., “Synthetic Analogues of the Bacterial Signal (Quorum Sensing) Molecule N-(3-Oxododecanoyl)-L-homoserine Lactone as Immune Modulators,” J. Med. Chem. 2003, 46, pp. 97-104.
Stickler, D. J., et al., “Biofilms on Indwelling Urethral Catheters Produce Quorum-Sensing Molecules in Situ and In Vitro,” Applied and Environmental Microbiology, Sep. 1998, pp. 3486-3490.
Dong, Y. H., et al., “Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase,” Nature, vol. 411, Jun. 14, 2001, pp. 813-817.
Schaefer, A. L., et al., “Quorum Sensing inVibrio fischeri; Probing Autoinducer-LuxR Interactions with Autoinducer Analogs,” Journal of Bacteriology, May 1996, pp. 2897-2901.
Zhu j., et al., “Anagogs of Autoinducer 3-Oxooctanoyl-Homoserine Lactone Strongly Inhibit Activity of the TraR Protein ofAgrobacterium tumefaciens,” Journal Bacteriology, Oct. 1998, pp. 5398-5405.
McClean, K. H., et al., “Quorum sensing andChromobacterium violaceum:exploitation of violacein production and inhibition for the detection of N-acelhomoserine lactones,” Microbiology 143, 1997, 3703-3711.
Swift S., et al., “Quorum Sensing inAeromonas hydrophilaandAeromonas salmonicida:Identification of the LuxRI Homologs AhyRI and AsaRI and Their Cognate N-Acylhomoserine Lactone Signal Molecules,” Journal of Bacteriology, Sep. 1997, pp. 5271-5281.
Pesci, E. C., et al., “Regulation of las and rhl Quorum Sensing inPseudomonas aeruginosa,” Journal of Bacteriology, May 1997, pp. 3127-3132.
Hentzer, M., et al., “Inhibition of quorum sensing inPseudomonas aeruginosabiofilm bacteria by a halogenated furonone compound,” Microbiology, 148, 2002, pp. 87-102.
Smith, K. M., et al., “Library Screening for Synthetic Agonists and Antagonists of aPseudomonas aeruginosaAutoinducer,” Chemistry & Biology, vol. 10, pp. 563-571, Jun. 2003.
Fuqua, W. C., et al., “Quorum Sensing in Bacteria: the LuxR-LuxI Family of Cell Density-Responsive Transcriptional Regulators,” Journal of Bacteriology, Jan. 1994, pp. 269-275.
Oikawa, Y., et al., “Methyl Phenylacetylacetate from Phenylacetyl Chloride and Meldrum's Acid,”Organic Syntheses, CV 7, pp. 359-360.
Oikawa, Y., et al., “Meldrum's Acid in Organic Synthesis 2. A General and Versatile Synthesis of β-Keto Esters,” J. Org. Chem., vol. 43, No. 10, pp. 2087-2088, 1978.
Nakahata, M., et al., “The Preparation of Optically Pure 3-Hydroxyalkanoic Acid. The Enantioface-differentiating Hydrogenation of the C=O Double Bond with Modified Raney Nickel. XXXVII,” Bull. Chem. Soc. Jpn, 55, pp. 2186-2189, 1982.
Matsuo, K., “Structure-Activity Relationships in Tetramic Acids and Their Copper (II) Complexes,” Chem. Pharm. Bull. 28, pp. 2494-2502, 1980.
Monti, L., et al., “Sulla preparazione delle α-ossi-γ-metil-chinoline,” Gass. Chim. Ital. 66, pp. 723-731, 1936.
Dekhane, M., et al., “A Novel Convenient Rout to the Naturally Occurring 3-Oxoacyl-L-Homoserinelactones and Related Bacterial Autoinducers,” Tetrahedron Letters, vol. 37, No. 11, pp. 1883-1884, 1996.
Augelli-Szafran, C., et al., “Inhibitors of Acyl-CoA: Cholesterol Acyltransferase. 5. Identification and Structure-Activity Relationships of Novel β-Ketoamides as Hypocholesterolemic Agents,” J. Med. Chem., 36, pp. 2943-2949, 1993.
Rowley, M., et al., “3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically Active Anticonvulsa

Affiliated with

Also associated with

Rating

Modulation of pathogenicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of pathogenicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of pathogenicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3950433